IFC are delighted to have been appointed by Cambridge Cognition to act as their Financial PR and Investor Relations advisers.
Cambridge Cognition (AIM: COG) is a neuroscience digital health company specialising in the precise measurement of clinical outcomes in neurological disorders. The Company develops, and markets validated near patient assessment products using cognition as a biomarker to improve understanding, diagnosis and treatment in brain health worldwide.
IFC will be working with Cambridge Cognition to build its broker, analyst and wider stakeholder followings by increasing its exposure to national dailies and creating a strong brand image and asserting a gripping story.
IFC Advisory advises on the Euro 128m sale of LSE listed Yew Grove REIT plc
IFC Advisory advises on the Euro 128m sale of LSE listed Yew Grove REIT plc, [...]
Feb
IFC Advisory advises on the sale of AIM listed Universe Group plc
IFC Advisory advises on the sale of AIM listed Universe Group plc, a leading developer [...]
Jan
Vector Capital appoint IFC Advisory
IFC Advisory appointed Financial PR adviser to AIM listed Vector Capital, the commercial lending group [...]
Jan